埃博拉病毒是否更“狡猾”？《细胞》杂志发布中大团队新发现

Core Insights - The research team revealed a key "advantage" mutation of the Ebola virus during the 2018-2020 outbreak, providing important scientific clues for understanding viral mutations and developing new antiviral strategies [2][3] Group 1: Research Findings - The study analyzed 480 full genomes of the Ebola virus (EBOV) and identified the GP-V75A mutation, which emerged early in the outbreak and quickly replaced the original strain, correlating with a significant increase in cases [2] - The GP-V75A mutation significantly enhances EBOV's infectivity in various host cells and mice, stabilizing protein conformation and improving the binding of the glycoprotein (GP) to the virus receptor NPC1, while reducing dependence on host tissue proteases during cell entry [3] - The mutation may weaken the effectiveness of some existing therapeutic antibodies and small molecule inhibitors, indicating a potential risk of drug resistance [3] Group 2: Implications and Funding - The research emphasizes the importance of real-time genomic monitoring and evolutionary analysis of pathogens during major emerging infectious disease outbreaks, which can help predict changes in virus transmission risks and assess the effectiveness of existing drugs and vaccines [3] - The study received funding from various sources, including the Shenzhen Science and Technology Program, Guangdong Province Key Research and Development Program, and the National Natural Science Foundation [3]